| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |